Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amplifybio, Astrazeneca, Avista Public Acquisition, Bavarian Nordic, Chromadex, Genmab, Ligand, Logicbio, Omeros, Omniab, Oxford Biotherapeutics, Pact and Venatorx.